Sysmex KK

6869

Equity

ISIN JP3351100007 / Valor 910976

Tokyo Stock Exchange (2024-11-20)

JPY 3,072.00-2.10%

Sysmex KK
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Sysmex KK, known by its Valor number 910976, is a publicly traded company. The stock of the company is available through the stock provider Tokyo Stock Exchange. As of 20.11.2024, the current price of the stock is JPY 3072. The latest price change for this stock is -2.1%, which reflects the market’s response to various factors such as company performance, industry trends, and global economic conditions. The company has been evaluated by users of Umushroom, and has received a rating of 0.00 stars.

Summarized from source with an LLMView SourceSector: Healthcare

Revenue Growth

Sysmex KK reported a significant increase in revenue for the first quarter of the fiscal year ending March 31, 2025. The company's net sales grew by 17.4% year-on-year, reaching a record high. This growth was driven by strong performance across all regions, particularly in the Asia-Pacific (AP) region.

Operating Profit

Operating profit for Sysmex KK in the first quarter of the fiscal year ending March 31, 2025, saw a substantial increase of 26.1% compared to the same period in the previous year. This rise was attributed to an improved cost of sales ratio and increased net sales, despite higher selling, general, and administrative (SG&A) expenses.

Profit Attributable to Owners

Sysmex KK's profit attributable to owners of the parent for the first quarter of the fiscal year ending March 31, 2025, rose by 28.0% year-on-year. This increase was supported by favorable exchange rate fluctuations and robust sales growth in key markets.

Segment Performance

In the first quarter of the fiscal year ending March 31, 2025, Sysmex KK's hematology segment performed exceptionally well, driven by the impact of the XR-Series and expansion in emerging markets. Additionally, the medical robotics business in Japan showed significant growth, contributing to the overall positive performance.

Financial Outlook

Sysmex KK's financial forecast for the fiscal year ending March 31, 2025, remains optimistic. The company expects to achieve double-digit growth for the Group, with performance in the first half and full year anticipated to align with initial forecasts. This outlook is based on the successful implementation of growth strategies in individual regions.

Summarized from source with an LLMView Source

Key figures

18.4%1Y

-37.2%3Y

20.1%5Y

Performance

31.0%1Y

38.1%3Y

36.1%5Y

Volatility